Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E T Zambidis

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 14, 1996
Epitope-specific tolerance induction with an engineered immunoglobulinE T Zambidis, D W Scott
Molecular Medicine (Cambridge, Mass.)|March 1, 1997
Genetically transferred central and peripheral immune tolerance via retroviral-mediated expression of immunogenic epitopes in hematopoietic progenitors or peripheral B lymphocytesE T Zambidis, A Kurup, D W Scott
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1997
Both resting and activated B lymphocytes expressing engineered peptide-Ig molecules serve as highly efficient tolerogenic vehicles in immunocompetent adult recipientsE T Zambidis, R K Barth, D W Scott
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|May 14, 1996
Epitope-specific tolerance induction with an engineered immunoglobulinE T Zambidis, D W Scott
Molecular Medicine (Cambridge, Mass.)|March 1, 1997
Genetically transferred central and peripheral immune tolerance via retroviral-mediated expression of immunogenic epitopes in hematopoietic progenitors or peripheral B lymphocytesE T Zambidis, A Kurup, D W Scott
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1997
Both resting and activated B lymphocytes expressing engineered peptide-Ig molecules serve as highly efficient tolerogenic vehicles in immunocompetent adult recipientsE T Zambidis, R K Barth, D W Scott
Pageof 1